Alfa Rhythm Ltd.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Device Transactions Device companies raised a total of $1.2 billion in financing in the fourth quarter, a 16% decrease from Q3's $1.4 billion. Q4 turned out to have the second-lowest financing aggrega

Financings During the final quarter of 2015, start-up companies raised a total of $2.41 billion, $156 million less than the previous quarter but a 65% increase from Q4 2014's total of $1.46 billion. F